Carter, Drew <br/><br/>
Governments Need Better Guidance to Maximise Value for Money: The Case of Australia's Pharmaceutical Benefits Advisory Committee.  [electronic resource] 

 -  Applied health economics and health policy  Aug 2016 
 - 401-407 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1179-1896 
<br/><br/><label>Standard No.: </label>10.1007/s40258-015-0220-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Advisory Committees<br/>Australia<br/>Cost-Benefit Analysis<br/>Decision Making<br/>Financing, Government<br/>Health Policy--economics<br/>Humans<br/>Pharmaceutical Preparations--economics<br/>Quality-Adjusted Life Years<br/>Severity of Illness Index<br/>Value-Based Purchasing